FindTrial
Sign In

A Correlative Study on the Prophylactic Use of Antimicrobial Lock Solutions in Long-term PICC-related Infections in Cancer Patients

A Correlative Study on the Prophylactic Use of Antimicrobial Lock Solutions in Long-term PICC-related Infections in Cancer Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089612
Enrollment
Unknown
Registered
2024-09-11
Start date
2022-01-04
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor

Interventions

treatment group:The research group includes Group A (45 cases): heparin sodium (50U/mL)+cefazolin sodium (1.5mg/mL) were used to seal the chemotherapy gap,
control group:while Group B (45 cases): heparin sodium (50U/mL) was used to seal the tube.

Sponsors

Meishan City Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Ninety patients diagnosed with cancer and undergoing long-term PICC chemotherapy in the Oncology Department of our hospital from January 2022 to December 2022 were included as the study subjects.

Exclusion criteria

Exclusion criteria: Patients with a history of penicillin allergy, coagulation disorders, hemorrhagic diseases, known or suspected existing infections, or infections or injuries at the intended puncture site.

Design outcomes

Primary

MeasureTime frame
Two groups of patients were compared in terms of the number of catheter-related infections and .;—

Secondary

MeasureTime frame
patient satisfaction after catheterization;—

Countries

China

Contacts

Public ContactChunyan Du

Meishan City Hospital

574665534@qq.com+86 134 3861 1739

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026